Biopharma Insights
Asahi Kasei
Planova FG1 brings a step forward in biopharma manufacturing
Koki Obara, marketing manager, Asahi Kasei Medical, delves into the current biopharmaceutical environment, the critical role of virus removal filters, and how Planova FG1 stands to impact the development and production of biopharmaceuticals. Read more
3 Dec 2024
Leqembi, Donanemab and Tofersen: The End of the Journey or the First Step on the Road to Reversing Neurodegeneration?
Dr. Peter Hamley, Chief Scientific Officer at Samsara Therapeutics, explores whether developments in therapeutics for neurodegenerative diseases are truly disease modifying or addressing the symptoms of a deeper problem. Read more
16 Aug 2023
R&D revolution: A new paradigm of sourcing and landscaping for the pharma industry
Dr Robin Knight, Co-Founder & Co-CEO of IN-PART, discusses the emerging importance of outsourcing landscaping activities within the pharmaceuticals industry and the benefits of adopting an openly innovative approach that pools sources of innovation. Read more
12 Jul 2023
Enhancing Biotherapeutic Properties with Cell-Line Engineering
Neha Mishra, Ph.D, Senior Scientist Bioproduction at Revvity explores enhancing biotherapeutic properties with cell-line engineering. Read more
30 Jun 2023
Cell line development strategies fit for a new era of Bispecific Antibodies
Nicole Wakes, Senior Director Cell Line Development, and Simon Keen, Vice President Cell Line Development at Abzena, outline the strategies to overcome the challenges of developing BsAbs under increasing pressure for speed. Read more
26 Jun 2023
Science and tech combine to deliver cancer vaccine innovation
Scientific and technological innovation is accelerating the development of effective cancer vaccines, report Drs. Daina Vanags, Cori Gorman and Christian K. Schneider of Biopharma Excellence. Read more
12 Apr 2023
PeopleImages.com - Yuri A Shutterstock
Everest Medicines announces positive results in Phase 1b/2a clinical trial
Everest Medicines has announced positive results in the ongoing Phase 1b/2a clinical trial for the treatment of primary membranous nephropathy (pMN) with EVER001 (previously known as XNW1011). Read more
9 Dec 2024
IMA Life
IMA Life announces partnership with RheaVita
IMA Life has announced a strategic partnership with RheaVita, a pioneer in controlled, continuous freeze-drying technology for biopharmaceuticals. Read more
21 Nov 2024
ustas7777777/Shutterstock
Pheast presents new preclinical data for anti-CD24 macrophage checkpoint inhibitor
Pheast Therapeutics announced the presentation of new preclinical data for PHST001, an anti-CD24 antibody drug candidate that is designed to block a key macrophage "don't eat me" signal on cancer cells. Read more
12 Nov 2024
TierneyMJ / Shutterstock.com
Why Pharmaceutical Industry Needs a Digital Content Factory (DCF)?
Modern pharma brands pursue a higher degree of content personalisation to engage with diverse audiences. This means tighter deadlines, higher workloads, and a greater demand for skilled content creators than ever before. Read more
Portescap
How are drive systems for wearable and automatic drug delivery devices are central to the patient outcome?
Portescap’s business development manager for medical applications, Dave Beckstoffer, explains how drive systems for wearable and automatic drug delivery devices are central to the patient outcome. Read more
19 Dec 2024
Trong Nguyen Shutterstock
Securing the chain: The critical role of supply chain management in pharmaceutical packaging
Roel Winter, supply chain manager, Tjoapack discusses the critical role of supply chain management in pharmaceutical packaging. Read more
17 Dec 2024
ArisGlobal
Regulatory AI appetites are growing
ArisGlobal’s director of product management’s Agnes Cwienczek, reports on AI-boosted regulatory process automation and other top-level findings from a new Censuswide survey of senior life sciences regulatory professionals. Read more
16 Dec 2024
Purolite
Q&A: Purolite's Felix Solamo
We caught up with Purolite's Felix Solamo to look back on Bio International 2024 and what it meant for the company. Read more
13 Dec 2024
A9 STUDIO Shutterstock
How ready are you? Annex 1 and the impact of primary packaging
While it officially applies to the manufacture of sterile medicinal products in the European Union, the revised EU Good Manufacturing Practice (GMP) Annex 1 effectively reset the benchmark for quality standards across the globe. Read more
12 Dec 2024
Bruker Microbiology
Advanced microbial ID system accelerates product release testing
Stefan Karl, CEO, Mikrobiologisches Prüflabor, Innsbruck and Olaf Degen, director industry microbiology, Bruker Microbiology & Infection Diagnostics discuss how advanced microbial ID systems accelerate product release testing. Read more
10 Dec 2024
